With Illumina currently banned from shipping its DNA sequencers into China—in retaliation for the Trump administration’s ...

A Leeds-based creator of simulation software to train medical staff on laboratory equipment has secured £1m investment.

Shares of 10x Genomics and Illumina are down some 40% this year. Sales of their research equipment have been hurt by ...

While Pacific Biosciences' earnings were beat, shrinking sales, high debt, and poor macro environment do not inspire ...

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top ...

A Leeds-based company whose simulation software enables medical staff to train to use laboratory equipment and troubleshoot problems has raised a further £1m.

A tech company specialising in virtual training tools for medical lab equipment has secured £1 million to accelerate growth ...

Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, delivered an adjusted loss per share of 15 cents in first-quarter 2025, narrower than the year-ago adjusted loss of 26 ...

Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, delivered an adjusted loss per share of 15 cents in first-quarter 2025, narrower than the year-ago adjusted loss of 26 cents ...

Pacira BioSciences PCRX has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The following table provides a quick overview ...

For the quarter ended March 2025, Pacific Biosciences of California (PACB) reported revenue of $37.15 million, down 4.3% over the same period last year. EPS came in at -$0.15, compared to -$0.26 ...